Recent studies have shown that treatment of melanoma or EG7 tumor-bearing mice with TNKS inhibitors XAV939 or JW55 markedly delayed tumor growth with augmented anti-tumor immunity (21, 22, 24). This evidence concerns the gene TNKS and neoplasm.